Quint Media Inc Share Price Other OTC
Equities
US74874T1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
07/05 | IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc. | CI |
06/05 | Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction. | CI |
Sales 2022 | 0.57 47.34 | Sales 2023 | 0.61 50.59 | Capitalization | 5.54M 462M |
---|---|---|---|---|---|
Net income 2022 | -12M -1B | Net income 2023 | -30M -2.5B | EV / Sales 2022 | 4,49,15,754 x |
Net Debt 2022 | 3.98M 332M | Net Debt 2023 | 18.76M 1.56B | EV / Sales 2023 | 4,00,45,900 x |
P/E ratio 2022 |
-1.59
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.39% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 43 | 01/09/01 | |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/18/01 |
Trevor McCartney
IRO | Public Communications Contact | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 18/20/18 |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/18/01 |
Director of Finance/CFO | 43 | 01/09/01 |
1st Jan change | Capi. | |
---|---|---|
+18.35% | 123B | |
+14.80% | 107B | |
-4.39% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.51% | 16.23B | |
+2.42% | 13.43B | |
+24.12% | 11.32B |